GlassScriptPhysician profile
Nikolas Raufi
NPI 1851755995
$4,772.53
in general payments reported to CMS, 2019-2025
17 companies · $1,529 in 2025
The $1,529 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $135 · 2020: $112 · 2021: $334 · 2022: $771 · 2023: $1,355 · 2024: $537 · 2025: $1,529.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,420.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,864.68 | 2019-2025 | Clareon, Clareon Panoptix Pro, Argos |
| Glaukos Corporation | $856.80 | 2021-2025 | Idosetr, Istent Infinite, Istent Infinite Trabecular Micro-Bypass System Model Is3 |
| New World Medical,INC. | $673.63 | 2022-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Clearpath |
| Bausch & Lomb Americas INC. | $353.43 | 2022-2025 | Miebo, Xiidra |
| Harrow Eye, LLC | $205.20 | 2023-2025 | Iheezo |
| Biotissue Holdings INC. | $159.04 | 2023-2025 | |
| Allergan, INC. | $115.42 | 2021 | |
| Abbvie INC. | $97.28 | 2022-2024 | |
| Tarsus Pharmaceuticals, INC. | $78.13 | 2024-2025 | Xdemvy |
| Novartis Pharmaceuticals Corporation | $72.07 | 2022 | |
| Genentech USA, INC. | $70.20 | 2019 | |
| Sight Sciences, INC. | $63.58 | 2024-2025 | Omni Surgical System, Sion Surgical Instrument |
| Oyster Point Pharma, INC. | $52.54 | 2022-2025 | Tyrvaya |
| Johnson & Johnson Surgical Vision, INC. | $33.80 | 2024-2025 | Tecnis Iol |
| Horizon Therapeutics Plc | $30.75 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $28.20 | 2025 | |
| Rayner Intraocular Lenses Limited | $17.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nikolas Raufi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.